http://orcid.org/0000-0003-0662-1302
References
- Hu, Z.D., 2016. Circulating biomarker for malignant pleural mesothelioma diagnosis: pay attention to study design. Journal of thoracic disease, 8, 2674–2676.
- Lijmer, J.G., et al., 1999. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA, 282, 1061–1066.
- Rutjes, A.W., et al., 2005. Case-control and two-gate designs in diagnostic accuracy studies. Clinical chemistry, 51, 1335–1341.
- Sun, G., et al., 2017. miR-200b-3p in plasma is a potential diagnostic biomarker in oral squamous cell carcinoma. Biomarkers, [Epub ahead of print]. doi: 10.1080/1354750X.2017.1289241.